Tg Therapeutics (TGTX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $158.8 million.
- Tg Therapeutics' Shares Outstanding rose 182.37% to $158.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.8 million, marking a year-over-year increase of 182.37%. This contributed to the annual value of $156.2 million for FY2024, which is 312.85% up from last year.
- As of Q3 2025, Tg Therapeutics' Shares Outstanding stood at $158.8 million, which was up 182.37% from $158.8 million recorded in Q2 2025.
- Tg Therapeutics' 5-year Shares Outstanding high stood at $158.8 million for Q2 2025, and its period low was $141.5 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $151.0 million (2023), whereas its average is $150.2 million.
- In the last 5 years, Tg Therapeutics' Shares Outstanding skyrocketed by 2841.09% in 2021 and then surged by 162.68% in 2022.
- Quarter analysis of 5 years shows Tg Therapeutics' Shares Outstanding stood at $143.3 million in 2021, then increased by 2.19% to $146.4 million in 2022, then rose by 3.44% to $151.5 million in 2023, then increased by 3.13% to $156.2 million in 2024, then grew by 1.63% to $158.8 million in 2025.
- Its Shares Outstanding was $158.8 million in Q3 2025, compared to $158.8 million in Q2 2025 and $158.7 million in Q1 2025.